Feb 2018 $2 M No. 11 $2 to $10 million 4
Avantis Medical Systems Inc: Raise no. 11, Feb 2018 × Investors in this round 4 investors had bought by the notice of Mar 19, 2018: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $3 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice Anthony DiTonno · Executive Officer, Director Daniel Turner III · Director David Silverman · Director Michael Mayer · Director Phil English · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Anthony DiTonno, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 19, 2018. Read the notice at the SEC .
debt, options SEC Aug 2016 $2 M No. 10 $2 to $10 million 1
Avantis Medical Systems Inc: Raise no. 10, Aug 2016 × Investors in this round 1 investor had bought by the notice of Aug 17, 2016: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice Anthony DiTonno · Executive Officer, Director Camran Nezhat · Director Daniel Turner III · Director David Silverman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Anthony DiTonno, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 17, 2016. Read the notice at the SEC .
debt, options SEC Mar 2016 $2 M No. 9 Under $2 million 8
Avantis Medical Systems Inc: Raise no. 9, Mar 2016 × Investors in this round 8 investors had bought by the notice of Aug 17, 2016: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $3 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice Anthony DiTonno · Executive Officer, Director Camran Nezhat · Director Daniel Turner III · Director David Silverman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Anthony DiTonno, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 17, 2016. Read the notice at the SEC .
debt, options SEC Sep 2015 $2 M No. 8 $2 to $10 million 1
Avantis Medical Systems Inc: Raise no. 8, Sep 2015 × Investors in this round 1 investor had bought by the notice of Aug 17, 2016: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice Anthony DiTonno · Executive Officer, Director Camran Nezhat · Director Daniel Turner III · Director David Silverman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Anthony DiTonno, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 17, 2016. Read the notice at the SEC .
debt, options SEC Jun 2015 $1 M No. 7 Under $2 million 19
Avantis Medical Systems Inc: Raise no. 7, Jun 2015 × Investors in this round 19 investors had bought by the notice of Aug 17, 2016: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice Anthony DiTonno · Executive Officer, Director Camran Nezhat · Director Daniel Turner III · Director David Silverman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Anthony DiTonno, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 17, 2016. Read the notice at the SEC .
debt, options SEC Feb 2013 $10 M No. 6 $10 to $50 million 23
Avantis Medical Systems Inc: Raise no. 6, Feb 2013 × Investors in this round 23 investors had bought by the notice of Aug 17, 2016: 23 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $17 M offered; $7 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice Anthony DiTonno · Executive Officer, Director Camran Nezhat · Director Daniel Turner III · Director David Silverman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Anthony DiTonno, Chief Executive Officer. Source: SEC Form D and 4 amendments, newest notice filed Aug 17, 2016. Read the notice at the SEC .
debt, options SEC Jun 2011 $18 M No. 5 $10 to $50 million 40
Avantis Medical Systems Inc: Raise no. 5, Jun 2011 × Investors in this round 40 investors had bought by the notice of Jul 8, 2011: 40 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $18 M of $35 M offered; $17 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice John Reed · Executive Officer Matthew J. Jenusaitis · Executive Officer, Director Richard Randall · Executive Officer, Director Camran J. Nezhat · Director Howard J. Palefsky · Director John J. Savarese · Director Thomas J. Fogarty · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Funds to be used for working capital.”Signed by John Reed, Coo. Source: SEC Form D, newest notice filed Jul 8, 2011. Read the notice at the SEC .
equity, options SEC Apr 2011 $2 M No. 4 $2 to $10 million 9
Avantis Medical Systems Inc: Raise no. 4, Apr 2011 × Investors in this round 9 investors had bought by the notice of May 12, 2011: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $4 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice John Reed · Executive Officer Matthew J. Jenusaitis · Executive Officer, Director Richard Randall · Executive Officer, Director Camran J. Nezhat · Director Howard J. Palefsky · Director Thomas J. Fogarty · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Funds to be used for working capital”Signed by Michael O'Donnell, Secretary. Source: SEC Form D, newest notice filed May 12, 2011. Read the notice at the SEC .
debt, options SEC Nov 2010 $2 M No. 3 $2 to $10 million 7
Avantis Medical Systems Inc: Raise no. 3, Nov 2010 × Investors in this round 7 investors had bought by the notice of Feb 15, 2011: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $5 M offered; $2 M still to sell
Smallest investment taken $25,000
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice John Reed · Executive Officer Matthew Jenusaitis · Executive Officer, Director Camran Neshat · Director Howard Palefsky · Director Thomas Fogarty · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Funds to be used for working capital.”Signed by Ann Coppel, Sr. Legal Assistant. Source: SEC Form D and 1 amendment, newest notice filed Feb 15, 2011. Read the notice at the SEC .
debt, options SEC Jun 2010 $3 M No. 2 $2 to $10 million 21
Avantis Medical Systems Inc: Raise no. 2, Jun 2010 × Investors in this round 21 investors had bought by the notice of Aug 26, 2010: 21 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $5 M offered; $2 M still to sell
Smallest investment taken $25,000
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice John Reed · Executive Officer Matthew Jenusaitis · Executive Officer, Director Camran Nezhat · Director Howard Palefsky · Director Thomas Fogarty · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Funds to be used for working capital.”Signed by Ann Coppel, Sr. Legal Assistant. Source: SEC Form D and 1 amendment, newest notice filed Aug 26, 2010. Read the notice at the SEC .
debt, options SEC Dec 2009 $1 M No. 1 Under $2 million 2
Avantis Medical Systems Inc: Raise no. 1, Dec 2009 × Investors in this round 2 investors had bought by the notice of Dec 17, 2009: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $4 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice Matthew J. Jenusaitis · Executive Officer, Director Scott Dodson · Executive Officer, Director Camran J. Nazhat · Director Fred R. Seddiqui · Director Howard J. Palefsky · Director Thomas J. Fogarty · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Funds to be used for working capital.”Signed by Ann Coppel, Sr. Legal Assistant. Source: SEC Form D, newest notice filed Dec 17, 2009. Read the notice at the SEC .
debt, options SEC